Cencora (COR) Competitors $285.46 +7.06 (+2.53%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$285.20 -0.26 (-0.09%) As of 08/8/2025 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock COR vs. ELV, MCK, CAH, HSIC, OMI, DHR, CVS, LH, NTRA, and ICLRShould you be buying Cencora stock or one of its competitors? The main competitors of Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Owens & Minor (OMI), Danaher (DHR), CVS Health (CVS), Labcorp (LH), Natera (NTRA), and Icon (ICLR). These companies are all part of the "medical" sector. Cencora vs. Its Competitors Elevance Health McKesson Cardinal Health Henry Schein Owens & Minor Danaher CVS Health Labcorp Natera Icon Elevance Health (NYSE:ELV) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations. Which has more volatility and risk, ELV or COR? Elevance Health has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Does the media refer more to ELV or COR? In the previous week, Cencora had 27 more articles in the media than Elevance Health. MarketBeat recorded 60 mentions for Cencora and 33 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.39 beat Cencora's score of 1.13 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 27 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cencora 33 Very Positive mention(s) 6 Positive mention(s) 15 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in ELV or COR? 89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 10.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is ELV or COR more profitable? Elevance Health has a net margin of 2.83% compared to Cencora's net margin of 0.60%. Cencora's return on equity of 267.36% beat Elevance Health's return on equity.Company Net Margins Return on Equity Return on Assets Elevance Health2.83% 17.59% 6.36% Cencora 0.60%267.36%4.31% Is ELV or COR a better dividend stock? Elevance Health pays an annual dividend of $6.84 per share and has a dividend yield of 2.3%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. Elevance Health pays out 29.1% of its earnings in the form of a dividend. Cencora pays out 22.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and Cencora has increased its dividend for 15 consecutive years. Do analysts prefer ELV or COR? Elevance Health currently has a consensus price target of $418.19, suggesting a potential upside of 42.08%. Cencora has a consensus price target of $309.83, suggesting a potential upside of 8.54%. Given Elevance Health's higher possible upside, analysts clearly believe Elevance Health is more favorable than Cencora.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Elevance Health 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.67Cencora 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has stronger earnings and valuation, ELV or COR? Elevance Health has higher earnings, but lower revenue than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioElevance Health$189.25B0.35$5.98B$23.5012.52Cencora$293.96B0.19$1.51B$9.7229.37 SummaryElevance Health and Cencora tied by winning 9 of the 18 factors compared between the two stocks. Get Cencora News Delivered to You Automatically Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COR vs. The Competition Export to ExcelMetricCencoraMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$55.26B$7.33B$5.53B$20.74BDividend Yield0.77%2.75%4.60%3.66%P/E Ratio29.3765.5630.0628.08Price / Sales0.1930.78448.6455.89Price / Cash14.3425.7836.7723.06Price / Book25.0417.878.194.33Net Income$1.51B$243.10M$3.27B$994.81M7 Day Performance-0.99%2.42%6.14%1.97%1 Month Performance-3.99%-4.08%0.07%-1.60%1 Year Performance20.06%18.47%36.43%14.35% Cencora Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORCencora4.2212 of 5 stars$285.46+2.5%$309.83+8.5%+20.1%$55.26B$293.96B29.3746,000News CoveragePositive NewsEarnings ReportDividend AnnouncementAnalyst RevisionELVElevance Health4.9043 of 5 stars$279.75+1.9%$418.19+49.5%-44.7%$63.00B$177.01B11.91104,200News CoveragePositive NewsMCKMcKesson4.6405 of 5 stars$707.85+1.3%$710.17+0.3%+23.3%$88.63B$359.05B27.4245,000News CoveragePositive NewsEarnings ReportAnalyst ForecastAnalyst RevisionCAHCardinal Health4.6457 of 5 stars$158.27+1.5%$158.07-0.1%+56.4%$37.83B$226.83B24.7348,900News CoveragePositive NewsUpcoming EarningsHSICHenry Schein4.0953 of 5 stars$69.43+2.1%$78.08+12.5%-4.4%$8.44B$12.67B21.6625,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionOMIOwens & Minor4.8057 of 5 stars$6.80+3.5%$11.60+70.6%-53.5%$528.42M$10.72B-1.4423,200News CoverageUpcoming EarningsAnalyst UpgradeOptions VolumeGap UpDHRDanaher4.8468 of 5 stars$196.27-0.4%$247.61+26.2%-25.1%$140.53B$23.88B41.7663,000News CoveragePositive NewsCVSCVS Health4.9985 of 5 stars$62.31-0.3%$75.39+21.0%+14.7%$79.11B$372.81B17.42300,000Positive NewsLHLabcorp4.6212 of 5 stars$265.50+1.5%$289.58+9.1%+17.5%$22.22B$13.01B29.3170,000Positive NewsNTRANatera3.5663 of 5 stars$133.92-0.5%$183.76+37.2%+32.6%$18.32B$1.70B-91.294,434Trending NewsEarnings ReportAnalyst ForecastInsider TradeGap UpICLRIcon4.17 of 5 stars$166.70+0.2%$219.54+31.7%-49.4%$13.40B$8.09B17.0841,900 Related Companies and Tools Related Companies ELV Competitors MCK Competitors CAH Competitors HSIC Competitors OMI Competitors DHR Competitors CVS Competitors LH Competitors NTRA Competitors ICLR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:COR) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cencora, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cencora With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.